TickerFacts.

Omada Health, Inc. (OMDA): R&D Expense

Annual figures by period end, from SEC filings.

$40.68M
Year ended 2025-12-31
$49.17M
Trailing 12 months to 2026-06-30
2023-12-31: $33.74M2024-12-31: $35.92M2025-12-31: $40.68M$40.68M
2023-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$40.68M+13.3%2026-03-06, From 2025-01-01
2024-12-31$35.92M+6.5%2026-03-06, From 2024-01-01
2023-12-31$33.74Mn/a2026-03-06, From 2023-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Omada Health, Inc. (OMDA)2025-12-31$40.68M+13.3%
DocGo Inc. (DCGO)2025-12-31$13.56M+17.0%
GeneDx Holdings Corp. (WGS)2025-12-31$72.03M+57.5%
EUDA Health Holdings Ltd (EUDA)2025-12-31$249n/a

Compare OMDA, DCGO, WGS, EUDA side by side · Screen every company in Services-Health Services ↗